The Claim
In obese mice treated with semaglutide, inhibition of 15-hydroxyprostaglandin dehydrogenase (15-PGDH) by SW033291 increases muscle stem cell proliferation, restores the size of regenerating myofibers following injury, and improves muscle strength recovery without altering the extent of weight loss.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In obese mice receiving semaglutide, blocking the enzyme 15-PGDH with SW033291 increases muscle stem cell activity, restores muscle fiber size after injury, and improves muscle strength recovery without changing weight loss.
See the scientific wording
In obese mice treated with semaglutide, inhibition of 15-hydroxyprostaglandin dehydrogenase (15-PGDH) with SW033291 enhances muscle stem cell proliferation and restores regenerating myofiber size after injury, leading to improved muscle strength recovery without reducing weight loss, suggesting a mechanistic pathway to counteract GLP-1 receptor agonist-induced impairments in muscle regeneration.
When a weight-loss drug suppresses appetite, muscle stem cells enter a dormant state and cannot grow new muscle fibers after injury. Blocking a specific enzyme allows a signaling molecule to build up, which wakes up the stem cells, makes them multiply, and helps them form larger, stronger muscle fibers without changing how much weight is lost.
What the research says
1 studyIn obese mice taking a weight-loss drug called semaglutide, muscle recovery after injury was weak—but when scientists blocked a specific enzyme (15-PGDH), the muscles healed better and got stronger, without stopping the weight loss.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.